Home
Care / Infusion pharmacies would also required to transmit drug
charges electronically using NCPDP V5.1. I would agree that the 278 is the
correct avenue for securing a PA for a particular drug.
Deborah McIntosh
Systems Analyst - HIPAA EDI Coordinator
Community Health Network
Indianapolis, IN
(317)
621-7151
--------Original Message-----
From: Drexler, Deborah [mailto:[EMAIL PROTECTED]
Sent: Thursday, May 29, 2003 1:10 PM
To: WEDI SNIP Transactions Workgroup List
Subject: RE: 278 QuestionIt is my understanding that the NCPDP is intended to be used only in the retail pharumacy situation. The proper transaction for a prescriber who seeks PA for a particular drug is the 278. We are acting accordingly. Does anyone have a different impression?Deborah Drexler, JD
Director of Privacy Compliance
Commonwealth Medicine
University of Massachusetts Medical School
Benedict Building, 55 Lake Avenue, Worcester 01655
ph 508-334-7096 fx 508-856-1212
[EMAIL PROTECTED]--------Original Message-----
From: [EMAIL PROTECTED] [mailto:[EMAIL PROTECTED]
Sent: Tuesday, May 27, 2003 4:50 PM
To: WEDI SNIP Transactions Workgroup List
Subject: 278 QuestionThe Minnesota HIPAA Collaborative subgroup for Data Issues is currently working through the 278 guide to collectively review and document a companion guide. A question came up that we would like to pose to this listserv.Is the 278 intended to be used for prior authorizations for pharmacy (i.e. medications)? Not commercial pharmacies but by providers or care systems? If so, are organizations planning to use the 278 for this?
The WEDI SNIP listserv to which you are subscribed is not moderated. The discussions on this listserv therefore represent the views of the individual participants, and do not necessarily represent the views of the WEDI Board of Directors nor WEDI SNIP. If you wish to receive an official opinion, post your question to the WEDI SNIP Issues Database at http://snip.wedi.org/tracking/. These listservs should not be used for commercial marketing purposes or discussion of specific vendor products and services. They also are not intended to be used as a forum for personal disagreements or unprofessional communication at any time.
You are currently subscribed to wedi-transactions as: [EMAIL PROTECTED]
To unsubscribe from this list, go to the Subscribe/Unsubscribe form at http://subscribe.wedi.org or send a blank email to [EMAIL PROTECTED]
If you need to unsubscribe but your current email address is not the same as the address subscribed to the list, please use the Subscribe/Unsubscribe form at http://subscribe.wedi.org
The WEDI SNIP listserv to which you are subscribed is not moderated. The discussions on this listserv therefore represent the views of the individual participants, and do not necessarily represent the views of the WEDI Board of Directors nor WEDI SNIP. If you wish to receive an official opinion, post your question to the WEDI SNIP Issues Database at http://snip.wedi.org/tracking/. These listservs should not be used for commercial marketing purposes or discussion of specific vendor products and services. They also are not intended to be used as a forum for personal disagreements or unprofessional communication at any time.
You are currently subscribed to wedi-transactions as: [EMAIL PROTECTED]
To unsubscribe from this list, go to the Subscribe/Unsubscribe form at http://subscribe.wedi.org or send a blank email to [EMAIL PROTECTED]
If you need to unsubscribe but your current email address is not the same as the address subscribed to the list, please use the Subscribe/Unsubscribe form at http://subscribe.wedi.org
